Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Boletín médico del Hospital Infantil de México
versión impresa ISSN 1665-1146
Resumen
MORENO-NOGUEZ, Moisés et al. Risk factors associated with SARS-CoV-2 pneumonia in the pediatric population. Bol. Med. Hosp. Infant. Mex. [online]. 2021, vol.78, n.4, pp.251-258. Epub 23-Ago-2021. ISSN 1665-1146. https://doi.org/10.24875/bmhim.20000263.
Background:
Currently, there are a few studies on the clinical characteristics of the pediatric population with COVID-19 and pneumonia. This study aimed to analyze data associated with the development of pneumonia in children and adolescents with SARS-CoV-2 infection throughout Mexico.
Methods:
We conducted a secondary analysis of the database of the Dirección General de Epidemiología of the Mexican Government. We included children under the age of 19 who were confirmed with SARS-CoV-2 infection by reverse transcription-polymerase chain reaction (RT-PCR) test. The dependent variable was the diagnosis of pneumonia. Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated. Multiple logistic regression models were performed to adjust factors associated with pneumonia.
Results:
A total of 1443 children with a COVID-19 diagnosis were included. The median age of the participants was 12 years (interquartile range 25, 75: 5, 16). Pneumonia occurred in 141 children (9.8%). The main risk factors were age < 3 years (OR, 3.5; 95%CI, 2.45-5.03); diabetes or obesity (OR, 12.6; 95%CI, 4.62-34.91); and immunocompromise (OR, 7.03; 95%CI, 3.97-13.61).
Conclusions:
Children < 3 years with COVID-19 and comorbidities, especially diabetes or obesity, and immunocompromised patients have a higher risk of developing pneumonia.
Palabras llave : Pneumonia; COVID-19; Risk-factors; Pediatrics.